Marx Biotechnology

Develops a blood test to diagnose the early onset of graft-versus-host disease (GVHD).

Health Tech & Life Sciences
Active
Seed Jerusalem, Israel Founded 2011
Last updated 2026-07-26
Total raised
—
Last: Grant 2019-09
Stage
Seed
Founded
2011
Headcount
2
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

Marx Biotechnology is a Jerusalem-based startup focused on developing diagnostic and pharmaceutical products. Their primary product is a blood test for the early diagnosis of Graft-versus-host disease (GVHD), which aims to save lives, reduce costs, and improve patient care by allowing for quick, accurate, and efficient treatment decisions. The company's technology analyzes the GSK-3β molecule to identify abnormalities linked to various diseases. They have completed animal trials and a pilot project on humans and are looking to raise a Series A funding round. Marx Biotechnology (MBT) has two patents that are in the final stages and a third pending in Israel. MBT has also submitted a Pre-IDE to the FDA and received an NSR letter, allowing them to proceed with a discovery trial.

Offices

Jerusalem, Israel · HQ / main office

Q&A

What is Marx Biotechnology's primary focus?
Marx Biotechnology (MBT) develops a blood test to diagnose the early onset of graft-versus-host disease (GVHD) to improve patient care and reduce costs.
How many employees does Marx Biotechnology have?
Marx Biotechnology has 1-10 employees.
When was Marx Biotechnology founded?
Marx Biotechnology was founded in January 2011.
What is Marx Biotechnology's total funding to date?
Marx Biotechnology has raised a total of $1,215,000 USD.
When was Marx Biotechnology's most recent funding round?
Marx Biotechnology's most recent funding round was a Grant in September 2019, with EU Horizon 2020 as an investor.
Who is the founder and CEO of Marx Biotechnology?
Stephen Marx Ph.D. is the Founder & CEO of Marx Biotechnology.
What is the product stage of Marx Biotechnology's offerings?
Marx Biotechnology's product is currently in the R&D stage.
Does Marx Biotechnology hold any patents?
Yes, Marx Biotechnology holds 1 patent.

Team · 8

Stephen G. Marx
Founder · Founder & CEO
Ariel Orbach
CTO
Yehoshua Levin-Landau
Senior Business Advisor
Michael Horesh
Finance
Maxime Stevens
Executive Leadership
Dr. Major General Elder Granger
Board Member
Prof. Ella Naparstek
Board Member
Richard L. "Dick" Teters, Jr.
Board Member

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

medical-devicesdiagnosticsantibodieshospitalslaboratoriesdoctorsbiotechnologybiomarkersbig-datablood-testinflammatory-diseasesnon-invasivecancer
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitemarxbio.com
LinkedInlinkedin.com/company/2495418
YouTubeyoutube.com/channel/UCGv_j6ERjIYtKsp6J2SWZWQ

Identifiers & details

Founded2011-1
Employees (exact)2

Radar intelligence

Web history (Wayback)

Domainmarxbio.com

Certificate / subdomain footprint

Subdomains2

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)514545912
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2011-01-04
Purposeלעסוק בסוגי עיסוק שפורטו בתקנון
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2025
Active charges / liens0
Registry events0
Registered addressעלית הנוער 4 ירושלים